Bagsværd, Denmark, 20 February 2017 - On 2 February 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council ...
- Kiplinger•6 days ago
When investors are on the hunt for income-driving dividend stocks, they often gravitate toward utilities or consumer staples names. Conversely, pharmaceutical stocks are rarely seen as effective dividend stocks. Although drugs are also relatively non-cyclical, these stocks are often impacted by an ever-changing regulatory environment and the ever-changing strength or weakness of a drugmaker's portfolio and pipeline.
- GlobeNewswire•7 days agoTrading in Novo Nordisk shares by board members, executives and associated persons on 9 February and 13 February 2017
Bagsværd, Denmark, 14 February 2017 - This document discloses the data of the transaction(s) made in Novo Nordisk shares by the company`s board members, executives and their associated persons in accordance ...
NOVO-B.CO : Summary for Novo Nordisk B A/S - Yahoo Finance
Novo Nordisk A/S (NOVO-B.CO)
Copenhagen - Copenhagen Delayed Price. Currency in DKK
Add to watchlist
|Day's Range||244.60 - 249.80|
|52 Week Range||218.20 - 391.30|
|PE Ratio (TTM)||16.69|
|Dividend & Yield||1.12 (3.19%)|
|1y Target Est||N/A|